These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 2037377
1. Expression and immunogenicity of a streptococcal M protein epitope inserted in Salmonella flagellin. Newton SM, Kotb M, Poirier TP, Stocker BA, Beachey EH. Infect Immun; 1991 Jun; 59(6):2158-65. PubMed ID: 2037377 [Abstract] [Full Text] [Related]
7. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Newton SM, Jacob CO, Stocker BA. Science; 1989 Apr 07; 244(4900):70-2. PubMed ID: 2468182 [Abstract] [Full Text] [Related]
8. Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice. McEwen J, Levi R, Horwitz RJ, Arnon R. Vaccine; 1992 Apr 07; 10(6):405-11. PubMed ID: 1376012 [Abstract] [Full Text] [Related]
9. Expression and immunogenicity of V3 loop epitopes of HIV-1, isolates SC and WMJ2, inserted in Salmonella flagellin. Cattozzo EM, Stocker BA, Radaelli A, De Giuli Morghen C, Tognon M. J Biotechnol; 1997 Aug 28; 56(3):191-203. PubMed ID: 9304878 [Abstract] [Full Text] [Related]
10. Hypervariable region IV of Salmonella gene fliCd encodes a dominant surface epitope and a stabilizing factor for functional flagella. He XS, Rivkina M, Stocker BA, Robinson WS. J Bacteriol; 1994 Apr 28; 176(8):2406-14. PubMed ID: 7512552 [Abstract] [Full Text] [Related]
12. Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. Wu JY, Newton S, Judd A, Stocker B, Robinson WS. Proc Natl Acad Sci U S A; 1989 Jun 28; 86(12):4726-30. PubMed ID: 2471978 [Abstract] [Full Text] [Related]
14. Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains. Sbrogio-Almeida ME, Mosca T, Massis LM, Abrahamsohn IA, Ferreira LC. Infect Immun; 2004 May 28; 72(5):2546-55. PubMed ID: 15102762 [Abstract] [Full Text] [Related]
15. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. Dale JB, Chiang EC. J Infect Dis; 1995 Apr 28; 171(4):1038-41. PubMed ID: 7706785 [Abstract] [Full Text] [Related]
16. Protective immunity induced by an intranasal multivalent vaccine comprising 10 Lactococcus lactis strains expressing highly prevalent M-protein antigens derived from Group A Streptococcus. Wozniak A, Scioscia N, García PC, Dale JB, Paillavil BA, Legarraga P, Salazar-Echegarai FJ, Bueno SM, Kalergis AM. Microbiol Immunol; 2018 Jun 28; 62(6):395-404. PubMed ID: 29704396 [Abstract] [Full Text] [Related]
18. Antibody responses against flagellin in mice orally immunized with attenuated Salmonella vaccine strains. De Almeida ME, Newton SM, Ferreira LC. Arch Microbiol; 1999 Aug 28; 172(2):102-8. PubMed ID: 10415171 [Abstract] [Full Text] [Related]
19. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella. Whittle BL, Lee E, Weir RC, Verma NK. J Med Microbiol; 1997 Feb 28; 46(2):129-38. PubMed ID: 9060872 [Abstract] [Full Text] [Related]
20. Recombinant tetravalent group A streptococcal M protein vaccine. Dale JB, Chiang EY, Lederer JW. J Immunol; 1993 Aug 15; 151(4):2188-94. PubMed ID: 8345202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]